Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-007505
Filing Date
2025-12-04
Accepted
2025-12-04 10:24:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4746
  Complete submission text file 0001959173-25-007505.txt   6434
Mailing Address 480 PLEASANT STREET SUITE C400 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE C400 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51122 | Film No.: 251548542
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 Ireland
Business Address
Lurker Nancy (Reporting) CIK: 0001450485 (see all company filings)

Type: 144